Literature DB >> 8271922

Immunization with fibronectin binding protein from Staphylococcus aureus protects against experimental endocarditis in rats.

T Schennings1, A Heimdahl, K Coster, J I Flock.   

Abstract

Rats were immunized with a fusion protein (gal-FnBP) encompassing beta-galactosidase and the domains of fibronectin binding protein from Staphylococcus aureus responsible for binding to fibronectin. Antibodies against gal-FnBP were shown to block the binding of S. aureus to immobilized fibronectin in vitro. Endocarditis in immunized and non-immunized control rats was induced by catheterization via the right carotid artery, resulting in damaged aortic heart valves which became covered by fibrinogen and fibronectin. The catheterized rats were then infected intravenously with 1 x 10(5) cells of S. aureus. The number of bacteria associated with aortic valves was determined 1 1/2 days after the challenge infection and a significant difference in bacterial numbers between immunized and non-immunized groups was then observed (p < 0.05).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8271922     DOI: 10.1006/mpat.1993.1073

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  29 in total

1.  Immunization with alpha-toxin toxoid protects the cornea against tissue damage during experimental Staphylococcus aureus keratitis.

Authors:  E B Hume; J J Dajcs; J M Moreau; R J O'Callaghan
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Immunization for Prevention of Infective Endocarditis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-06       Impact factor: 3.725

3.  Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats.

Authors:  J C Lee; J S Park; S E Shepherd; V Carey; A Fattom
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

4.  Immunization with FimA protects against Streptococcus parasanguis endocarditis in rats.

Authors:  H B Viscount; C L Munro; D Burnette-Curley; D L Peterson; F L Macrina
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

5.  Lack of adherence of clinical isolates of Pseudomonas aeruginosa to asialo-GM(1) on epithelial cells.

Authors:  T H Schroeder; T Zaidi; G B Pier
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

6.  A bone sialoprotein-binding protein from Staphylococcus aureus: a member of the staphylococcal Sdr family.

Authors:  H s Tung; B Guss; U Hellman; L Persson; K Rubin; C Rydén
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

Review 7.  Corneal ulceration in pediatric patients: a brief overview of progress in topical treatment.

Authors:  Serina Stretton; Usha Gopinathan; Mark D P Willcox
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

8.  Clusterin, a putative complement regulator, binds to the cell surface of Staphylococcus aureus clinical isolates.

Authors:  S R Partridge; M S Baker; M J Walker; M R Wilson
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

9.  Development of Antistaphylococcal Vaccines.

Authors:  Jean C. Lee
Journal:  Curr Infect Dis Rep       Date:  2001-12       Impact factor: 3.725

10.  Chimeric plant virus particles administered nasally or orally induce systemic and mucosal immune responses in mice.

Authors:  F R Brennan; T Bellaby; S M Helliwell; T D Jones; S Kamstrup; K Dalsgaard; J I Flock; W D Hamilton
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.